Vista.ai  

431 Florence St.
Suite 100
Palo Alto,  CA  94301

United States
https://vista.ai
  • Booth: FH22


www.vista.ai

Vista.ai is harnessing the power of AI to offer clinicians an easy, cost-effective and stress-free way to conduct MRI studies. The company's FDA 510(k) cleared One Click MRI™ software-only solution automates and dramatically simplifies a CMR exam, enabling any MRI tech to perform a CMR in your regular mixed-use scanner time slot. Available for use on Siemens Healthineers and GE Healthcare MRI scanners, One Click MRI • Eliminates the need for specialized CMR technologist • Allows CMRs to fit into your mixed-use scanner standard time slot • Makes scans less stressful for the technologist • Gives patients greater comfort and convenience HeartVista is funded by Khosla Ventures, and the National Institute of Health's Small Business Innovation Research program.


 Videos

One Click MRI in Action

 Press Releases

  • CHICAGO — Nov. 27, 2022 — HeartVista, a pioneer and leader in automated MRI solutions, today announced that it has changed its name to Vista.ai as the company broadens its sights to simplify and enhance MRI exams for anatomies beyond the heart. A major academic medical center has already begun a clinical study to evaluate the software for use with the prostate, and Vista.ai plans to launch a similar study for musculoskeletal scans in the near future. The company made the announcement from the Radiological Society of North America (RSNA) 108th Scientific Assembly and Annual Meeting held Nov. 27-Dec. 1, 2022, in Chicago. 

    Vista.ai’s One Click MRI AI-driven software-only solution makes it easier to acquire high quality MRI images by automating the exam workflow. The company initially targeted cardiac MRI (CMR) as it is increasingly considered the gold-standard cardiac diagnostici, yet the heart is a notoriously difficult and time-consuming anatomy to scan. Today, specially-trained CMR technologists need to perform an exam, and in the U.S., there is only one such technologist for every 20 MRI machinesii. One Click MRI’s benefits include simple, streamlined workflows and improved image consistency, so any MRI technologist can complete a cardiac scan in a regular mixed-use MRI time slot. 

    Vista.ai is demonstrating One Click MRI this week at Booth 5143 in the AI Showcase during RSNA exhibit hours. In addition, Raymond Y. Kwong, MD, MPH, FACC, FSCMR Director of cardiac magnetic resonance imaging at Brigham and Women’s Hospital and Professor of medicine at Harvard Medical School, will share case studies and research findings using the software in his clinical cardiac MRI practice. Dr. Kwong will present at noon CST, Monday, Nov. 28, 2022, in the RSNA AI Theater (#5149). 

    Vista.ai developed One Click MRI using sophisticated and versatile AI-based algorithms that would be scalable to other types of MRI scans. The company chose the prostate and spine as its next candidates because of known challenges with those exams and the number of people who could benefit. In the U.S., more than 10 million people receive prostate and spine MRI scans annually, 25% of the total MRI volume.iii 

    “Given the complexity of manual CMR, and the millions of patients who could benefit from the exam, it was clear that applying our automation technology to the heart would create enormous value in the market. Despite the evidence-backed advantages of MRI for diagnosing a myriad of heart conditions, only 2% of scans today are CMRsiv yet 700,000 people are dying of heart disease each year in the U.S.v,” said Itamar Kandel, Vista.ai’s CEO. “But we always knew it was just the beginning. Once we had the most complex anatomy tested, validated, adopted and endorsed by several elite medical institutions, we planned to roll out to other anatomies that would share in the benefits we have shown for numerous heart diseases.” 

    Each year clinicians in the U.S. conduct almost 40 million examsvi on the approximately 12,000 MRI machines installed in the country.vii But MRI scanners are only beneficial if trained healthcare professionals are available to run the exam, which is an escalating concern. In 2019, the U.S. had 20,000 fewer healthcare professionals than necessary to meet the needs of Americansiii, a situation that only worsened during the COVID-19 pandemic. 

    “Radiologist and technologist burnout is at a breaking point, which has only worsened since the pandemic given the exodus of medical professionals, backlog of imaging cases and increasing incidence of COVID-related illnesses, such as myocarditis and pericarditis,” said Dr. Scott Flamm, Section Head of Cardiovascular Imaging at The Cleveland Clinic Foundation. “To address the staffing shortages – particularly for challenging, time-consuming procedures like CMR – we are in earnest need of automation technologies like Vista.ai’s One Click MRI to ensure patients anywhere can receive the quickest possible diagnosis and treatment.” 

    About Vista.ai 

    Vista.ai is harnessing the power of artificial intelligence (AI) to offer clinicians an easy, cost-effective and less stressful way to conduct MRI studies. The company’s FDA 510(k) cleared One Click MRI™ software-only solution automates and dramatically simplifies a CMR exam, enabling a hospital to obtain greater scanner throughput or get a CMR program off the ground cost-effectively. One Click MRI is available for use on Siemens Healthineers and GE Healthcare MRI scanners. Vista.ai is funded by Khosla Ventures and the National Institute of Health’s Small Business Innovation Research program. 

    For more information, visit www.vista.ai. For Vista.ai’s RSNA media toolkit, visit rsna.vporoom.com/HeartVista. 

    i Writing Committee Members, & ACC/AHA Joint Committee Members (2022). 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of cardiac failure28(5), e1–e167. https://doi.org/10.1016/j.cardfail.2022.02.010 

    ii Goldfarb JW, Weber J. Trends in Cardiovascular MRI and CT in the U.S. Medicare Population from 2012 to 2017. Radiol Cardiothorac Imaging. 2021 Feb 25;3(1):e200112. doi: 10.1148/ryct.2021200112. 

    iii Spine MRI Results and Medical Decision Making: Consider All Your Options. Elite Pain & Health. https://epainhealth.com/spine-mri-get-options/. Accessed Oct. 26, 2022. 

    iv Kalorama Information. MRI: World Market Analysis. November 2014. 

    v Heart Disease. Heart Disease Facts. U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/heartdisease/facts.htm. Accessed Oct. 24, 2022. 

    vi Conor Stewart. Number of MRI scans in the U.S. in 2016 and 2017, by facility type. Statista. https://www.statista.com/statistics/820927/mri-scans-number-in-us-by-facility-type/. Accessed Oct. 20, 2022. 

    vii Conor Stewart. Number of magnetic resonance imaging (MRI) units in selected countries as of 2019. Statista. https://www.statista.com/statistics/282401/density-of-magnetic-resonance-imaging-units-by-country/. Accessed Oct. 20, 2022. 

    viii Association of American Medical Colleges. The Complexities of Physician Supply and Demand: Projections from 2019 to 2034. June 2021. https://www.aamc.org/media/54681/download?attachment. Accessed Oct. 20, 2022.  

  • Palo Alto, Calif. — November 17, 2022 — HeartVista, a pioneer in AI-assisted MRI solutions, and Siemens Healthineers, a global leader in magnetic resonance (MR), today announced that they have entered a joint commercial agreement to co-market an integrated offering that brings best-in-class MRI scan sequences into one automated exam protocol. This new product offering will allow customers to combine HeartVista’s built-in sequences and Siemens Healthineers’ native sequences, to their individual clinical practices. 

    HeartVista’s AI-guided acquisition software, which shortens cardiac MRI (CMR) exam times, simplifies workflows and improves image consistency, previously received FDA 510(k) clearance for use with Siemens Healthineers MRI scanners. The companies have now advanced the software to comingle sequences from multiple sources using Access-i, a Siemens Healthineers software interface that allows third-party device integration with Siemens scanners. 

    Historically in the U.S., hospitals have largely underutilized CMRs, because they are often complex to perform, tie up scanners for lengthy periods, and the vast majority of clinicians are not trained to conduct them. With HeartVista’s One Click MRI acquisition software, any radiology technologist can perform a CMR, helping ensure that patients anywhere in the country can benefit. 

    “HeartVista’s mission is to make MRI available to everyone. Despite its clear benefits, the previous version of our software forced customers to choose between HeartVista’s automated sequences and manual ones that may be more familiar. On that basis alone, we restricted access to the broader market in direct conflict with our mission” said Itamar Kandel, CEO. “Working closely with Siemens Healthineers and implementing the Access-i interface, we have removed a key barrier to market adoption.” 

    CMR is a Class I, front-line test for the diagnosis of chest pain under guidelines from American Heart Association (AHA) and the American College of Cardiology (ACC). The test is considered the “gold-standard of cardiac diagnostics” due to its recommended use in the evaluation of all major heart conditions such as ischemic, valvular, myocardial, pericardial and aortic diseases. CMRs are also noninvasive and can be performed without subjecting patients to low levels of radiation. 

    “HeartVista’s AI-driven acquisition software is a valuable complement to our MRI scanners and library of scan sequences,” said Peter Gall, PhD, Vice President, Magnetic Resonance, Portfolio, Partners & Digital at Siemens Healthineers. “With this robust, integrated offering, hospitals can easily select the scan method that work best for them.”

    About HeartVista 

    HeartVista is harnessing the power of artificial intelligence to provide clinicians access to quick, accurate, and affordable MRI studies. The company’s One Click™ software platform enables real-time MRI for a variety of clinical and research applications. Its 510k cleared, AI-enabled, one-click cardiac localization method is available for use on Siemens Healthineers and GE healthcare MRIs and received first place honors at the International Society for Magnetic Resonance in Medicine’s Machine Learning Workshop in 2018. HeartVista is funded by Khosla Ventures, and the National Institute of Health’s Small Business Innovation Research program. 

    For more information visit www.heartvista.ai. 

    Media Contact: 

    Julie Johnson 619-888-8045 

  • SAN DIEGO — Jan. 26, 2023 — Vista.ai, a pioneer and leader in automated MRI solutions, today announced results from a clinical adaptation study on the company’s One Click MRI™ software, led by Dr. Raymond Kwong, Director, Cardiac Magnetic Resonance Imaging for Harvard-affiliated Brigham and Women’s Hospital. The findings show that Vista.ai’s AI-guided image acquisition software improves cardiac MRI (CMR) scan times and achieves high adoption rates by hospital imaging staff. Dr. Kwong will discuss the learnings and implications of the study at an interactive breakfast symposium at 7:20 a.m. PST on Jan. 27, 2023, at the SCMR Scientific Sessions in San Diego. 

    Dr. Kwong evaluated the use of One Click MRI across approximately 1,100 consecutive studies for cardiomyopathy and structural heart disease, comparing traditional CMR exams against both partial and full AI-assisted scans from April to September 2022. 

    With respect to CMR exam time, Dr. Kwong’s study found that: 

    • Full AI-assisted scans – where a technologist uses One Click MRI to oversee the exam with no manual operation – were 31% shorter than non-AI scans. 
    • 90% of full AI-assisted scans were completed within 45 minutes, while only 25% of unassisted scans were completed within that timeframe. 
    • Full AI-assisted scan times were threefold more consistent than unassisted scan times. Both had minimum times of 26 to 27 minutes; however, maximum times were 64 minutes versus 161 minutes, respectively. 

    Failed adoption of other promising technologies in the medical field has spotlighted the critical importance of gaining support of frontline workers. Notably, Dr. Kwong’s study found that voluntary use of One Click MRI steadily grew as technologists witnessed the software’s ease of use and benefits firsthand. Technologist adoption increased from 13% during the first full month One Click MRI was available (May) to 55% at the end of the study (September). 

    “An influx of patients with COVID-19-induced cardiac issues further strained the operation of our CMR program at Brigham. Before initiating the One Click MRI study, some outpatients were waiting up to three to four weeks for a CMR scan. Even our sickest inpatients would often have to wait two to five days for a scan,” Dr. Kwong said. “We believe that with continued use of One Click MRI, we will further reduce scan times to an average of 30 minutes, shrink the backlog to improve upon pre-pandemic levels, and sustain a CMR growth rate of about 15% a year.” 

    A case study summarizing Dr. Kwong’s full clinical findings is available at vista.ai/evidence/studies. In addition to demonstrations of One Click MRI, the case study will also be on display at the Vista.ai’s SCMR booth (#503). 

    “A standard CMR is complex and unpredictably long, causing unnecessary stress and burnout for clinicians and discomfort for patients,” said Itamar Kandel, Vista.ai’s CEO. “We applaud Dr. Kwong’s rigorous clinical evaluation of One Click MRI across more than 1,000 patients over a six-month timeframe, and we are thrilled with his conclusions that the software yields positive impacts on clinician workflow, MRI scanner throughput, patient convenience and time to diagnosis. These findings serve as a foundation of evidence to fuel our efforts to make CMR available to all patients who can benefit.” 

    One Click MRI is initially focused on automating and simplifying a CMR exam, which is increasingly considered the gold-standard cardiac diagnostici, yet is notoriously difficult and time-consuming to complete. Today, specially-trained CMR technologists need to perform the exam, and in the U.S., there is only one such technologist for every 20 MRI machinesii. Vista.ai recently announced planned expansion beyond the heart to other anatomies and clinical areas. 

    About Vista.ai 

    Vista.ai is harnessing the power of artificial intelligence (AI) to offer clinicians an easy, cost-effective and less stressful way to conduct MRI studies. The company’s FDA 510(k) cleared One Click MRI™ software-only solution automates and dramatically simplifies a CMR exam, enabling a hospital to obtain greater scanner throughput or get a CMR program off the ground cost-effectively. One Click MRI is available for use on Siemens Healthineers and GE Healthcare MRI scanners. Vista.ai is funded by Khosla Ventures, J-Ventures and the National Institute of Health’s Small Business Innovation Research program. 

    For more information, visit www.vista.ai. For Vista.ai’s media kit, visit vista.ai/media/. 

    Media Contact: 

    Alexander Petti 

    Alexander@TakeOnCommunications.com 

    201.978.4882 


    Writing Committee Members, & ACC/AHA Joint Committee Members (2022). 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. Journal of cardiac failure28(5), e1–e167. https://doi.org/10.1016/j.cardfail.2022.02.010 

    ii Goldfarb JW, Weber J. Trends in Cardiovascular MRI and CT in the U.S. Medicare Population from 2012 to 2017. Radiol Cardiothorac Imaging. 2021 Feb 25;3(1):e200112. doi: 10.1148/ryct.2021200112.


 Products

  • One Click MRI: scan planning
    30-second scan planning...

  • Fully automated localization and prescription removes stress and burden of intricate manual work flows.
  • One Click MRI: real-time artifact detection
    Real-time artifact detection...

  • Real-time artifact detection allows instant scan modifications, avoiding costly and time-consuming rescans after the initial exam is completed.
  • One Click MRI: in-line processing
    In-line processing...

  • In-line processing supports image acquisition, increasing producivity and shortening read times

 Additional Info

We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth!
Yes
ACC.23 Learning Pathways? (select all that apply)
Heart Failure and Cardiomyopathies, Ischemic Heart Disease, Pediatric and Congenital Heart Disease, Valvular Heart Disease
First time Exhibitor?
Yes